Summary: Cory Stieg of CNBC Make It illustrates the details of psychedelic-assisted therapy sessions, pulling from the expertise of MAPS-sponsored researcher Jennifer Mitchell, Ph.D., and Corine de Boer, M.D., Ph.D., of MAPS Public Benefit Corporation (MAPS PBC).
De Boer highlights that the focus of such treatment sessions is not the drug alone, but “a synergy between the participants, the therapists and the drugs.”
Originally appearing here.